Westover Capital Advisors LLC Sells 249 Shares of Synopsys, Inc. $SNPS

Westover Capital Advisors LLC reduced its stake in Synopsys, Inc. (NASDAQ:SNPS) by 9.1% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,497 shares of the semiconductor company’s stock after selling 249 shares during the period. Westover Capital Advisors LLC’s holdings in Synopsys were worth $1,280,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also added to or reduced their stakes in SNPS. Nuveen LLC bought a new stake in shares of Synopsys during the first quarter worth $341,480,000. Generation Investment Management LLP acquired a new stake in shares of Synopsys during the first quarter valued at about $240,491,000. Vanguard Group Inc. increased its stake in shares of Synopsys by 2.4% in the first quarter. Vanguard Group Inc. now owns 14,829,770 shares of the semiconductor company’s stock valued at $6,359,747,000 after buying an additional 346,994 shares during the period. Alliancebernstein L.P. increased its position in Synopsys by 22.2% in the 1st quarter. Alliancebernstein L.P. now owns 1,725,211 shares of the semiconductor company’s stock valued at $739,857,000 after acquiring an additional 313,218 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in shares of Synopsys by 20.2% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,816,319 shares of the semiconductor company’s stock worth $778,928,000 after purchasing an additional 305,489 shares during the last quarter. 85.47% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on SNPS shares. Wells Fargo & Company decreased their price target on Synopsys from $630.00 to $550.00 and set an “equal weight” rating for the company in a research note on Wednesday, September 10th. BNP Paribas initiated coverage on shares of Synopsys in a report on Thursday, October 2nd. They set an “underperform” rating and a $425.00 price target for the company. JPMorgan Chase & Co. dropped their price target on shares of Synopsys from $685.00 to $600.00 and set an “overweight” rating on the stock in a research report on Wednesday, September 10th. Robert W. Baird reaffirmed a “neutral” rating and issued a $535.00 price objective (down from $670.00) on shares of Synopsys in a research note on Wednesday, September 10th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Synopsys in a research note on Wednesday, October 8th. Nine analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $562.14.

Insider Transactions at Synopsys

In other news, CFO Shelagh Glaser sold 3,655 shares of the company’s stock in a transaction that occurred on Friday, September 5th. The stock was sold at an average price of $609.77, for a total transaction of $2,228,709.35. Following the transaction, the chief financial officer directly owned 15,317 shares of the company’s stock, valued at $9,339,847.09. This represents a 19.27% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Robert G. Painter purchased 350 shares of Synopsys stock in a transaction that occurred on Thursday, September 11th. The stock was acquired at an average cost of $425.44 per share, with a total value of $148,904.00. Following the transaction, the director owned 2,291 shares in the company, valued at $974,683.04. This trade represents a 18.03% increase in their position. The disclosure for this purchase is available in the SEC filing. In the last 90 days, insiders have sold 30,894 shares of company stock valued at $16,760,783. 0.62% of the stock is currently owned by corporate insiders.

Synopsys Stock Performance

Shares of SNPS stock opened at $390.24 on Tuesday. The firm has a 50 day moving average of $450.59 and a 200-day moving average of $513.13. The company has a market cap of $72.49 billion, a price-to-earnings ratio of 30.63, a price-to-earnings-growth ratio of 5.02 and a beta of 1.10. The company has a quick ratio of 1.51, a current ratio of 1.62 and a debt-to-equity ratio of 0.52. Synopsys, Inc. has a 52 week low of $365.74 and a 52 week high of $651.73.

Synopsys (NASDAQ:SNPS) last issued its earnings results on Tuesday, September 9th. The semiconductor company reported $2.30 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.75 by ($1.45). Synopsys had a return on equity of 10.82% and a net margin of 31.04%.The company had revenue of $1.74 billion for the quarter, compared to the consensus estimate of $1.77 billion. During the same period in the prior year, the company earned $3.43 earnings per share. The firm’s revenue was up 14.0% compared to the same quarter last year. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS. Q4 2025 guidance at 2.760-2.80 EPS. On average, equities analysts forecast that Synopsys, Inc. will post 10.64 earnings per share for the current year.

About Synopsys

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.